RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Echo Therapeutics Dividend 2024

Echo Therapeutics Dividend

0 USD

Echo Therapeutics Dividend yield

Ticker

ECTE

ISIN

US27876L2060

WKN

A1W0FG

How much dividend does Echo Therapeutics 2024 pay?

According to the latest status from June 2024, Echo Therapeutics paid a total of 0 USD per share in dividends within the last 12 months. With the current Echo Therapeutics price of 0 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Echo Therapeutics Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Echo Therapeutics Dividend Safe?

Echo Therapeutics has been increasing the dividend for 0 years.

Over the past 10 years, Echo Therapeutics has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Echo Therapeutics's Dividend Distributions

Echo Therapeutics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Echo Therapeutics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Echo Therapeutics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Echo Therapeutics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Echo Therapeutics Aktienanalyse

What does Echo Therapeutics do?

Echo Therapeutics Inc is a US-based company specializing in the development and marketing of innovative medical technology products. The company was founded in 2007 as a subsidiary of Sontra Medical Corporation. In 2009, it was renamed Echo Therapeutics, Inc. and went public in the same year. The goal of Echo Therapeutics is to revolutionize the treatment of diabetes, anesthesia monitoring, and wound care. The company is currently focused on enabling non-invasive real-time monitoring of blood glucose levels to improve the lives of diabetics. Echo Therapeutics has an innovative business model that focuses on the areas of medical technology and services. The company has made significant investments in research and development in recent years to bring innovative products to the market, aiming to provide patients with a higher quality of life and safety. Echo Therapeutics is segmented into various divisions to cover different areas of medical diagnostics and treatment. The company's main divisions include skin monitoring, diabetes monitoring, anesthesia monitoring, and automated wound care. Echo Therapeutics' skin monitoring is an advanced system for monitoring drug absorption through the skin. It is a transdermal system that allows for a non-invasive and painless procedure. Echo Therapeutics is a pioneer in the development of diabetes monitoring systems. Its glucose monitoring system is an important alternative to conventional invasive blood glucose measurement. The system uses continuous glucose monitoring technology and sends the data in real-time to the patient's handheld device or a hospital. This allows for real-time monitoring of blood glucose levels and quick response to changes. In addition, Echo Therapeutics offers comprehensive anesthesia monitoring, which enables continuous monitoring of ECG, pulse rate, SpO2, and blood pressure. Echo Therapeutics has also developed an advanced automated wound care system. In this system, wound fluid is constantly drained to enable improved diagnostics and targeted treatment of infected wounds. Echo Therapeutics' latest product is the Symphony CGM System, an innovative glucose monitoring solution. The Symphony CGM System is a transdermal system that measures glucose concentrations in interstitial fluid (ISF) and sends them in real-time to a smartphone app. This allows patients to monitor their glucose levels in an easy and convenient way without the need for occasional painful blood draws. In addition to its innovative products, Echo Therapeutics has a strong patent portfolio. These patents protect the company's intellectual property and strengthen its position in the competitive market of medical technologies. Echo Therapeutics is at the forefront of the medical technology industry and is recognized as a leader in various segments of diagnosis and treatment. The company places great emphasis on research and development of new technologies to promote high-quality healthcare. Its products aim to improve patients' lives and provide them with a higher quality of life. Answer: Echo Therapeutics Inc is a US-based company specializing in the development and marketing of innovative medical technology products. The company focuses on revolutionizing the treatment of diabetes, anesthesia monitoring, and wound care. It has made significant investments in research and development to bring innovative products to the market. Echo Therapeutics aims to improve the lives of patients and provide them with a higher quality of life. Echo Therapeutics is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Echo Therapeutics Stock

How much dividend does Echo Therapeutics pay?

Over the past 12 months, Echo Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Echo Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Echo Therapeutics?

The current dividend yield of Echo Therapeutics is .

When does Echo Therapeutics pay dividends?

Echo Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Echo Therapeutics?

Echo Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Echo Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Echo Therapeutics located?

Echo Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Echo Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Echo Therapeutics from 6/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Echo Therapeutics pay the last dividend?

The last dividend was paid out on 6/3/2024.

What was the dividend of Echo Therapeutics in the year 2023?

In the year 2023, Echo Therapeutics distributed 0 USD as dividends.

In which currency does Echo Therapeutics pay out the dividend?

The dividends of Echo Therapeutics are distributed in USD.

Andere Kennzahlen von Echo Therapeutics

Our stock analysis for Echo Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Echo Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.